Welcome
to Our Site
DR.INMACULADA
Enter a world where Aesthetic Regenerative Medicine merges precision with artistry. Each journey is thoughtfully curated — from age and treatment history to advanced injection protocols, cannula selection, dilution, and volume — every detail tailored to restore harmony, radiance, and lasting confidence.
DR.INMACULADA´S
PATIENT´S JOURNEY WITH
PLLA LASYNPRO.
1
PATIENT
ENTRY POINT
Vial 1 -At the intersection of a parallel line located 1 cm in front of the vertical ramus of the mandible with the parallel line 1 cm above the horizontal ramus of the mandible.
Vial 2 -
- 1 cm laterally from the oral commissure
-At the intersection of a parallel line located 1 cm in front of the vertical ramus of the mandible with the parallel line 1 cm above the horizontal ramus of the mandible.
Vial 3- - 1 cm laterally from the oral commissure
Recommendation: Spread (fanning technique) the product according to your patient´s needs in order to achieve a tailored made result and the best outcome.
VOLUME PER SIDE
2,5 - 75mg PLLA Lasynpro
TREATMENT INTERVAL
3 sessions were performed.
Each treatment/vial 4 weeks apart.
If previous material( calcium hydroxyapatite, polycaprolactone etc) my personal professional experience it is to at least wait 6 months after the last injection of those material was performed, in case any delayed complications from that previous material could appear.
LONG TERM PLAN
For this patient, currently, 1 vial of Julaine per year was recommended.
PATIENT AGE
36
PREVIOUS TREATMENT
None
INJECTION TECHNIQUE
Fanning on both sides of the face.
CANNULA
25 G cannula was used, subdermal.
2
PATIENT
ENTRY POINT
Vial 1 -At the intersection of a parallel line located 1 cm in front of the vertical ramus of the mandible with the parallel line 1 cm above the horizontal ramus of the mandible.
Vial 2 -
- 1 cm laterally from the oral commissure
-At the intersection of a parallel line located 1 cm in front of the vertical ramus of the mandible with the parallel line 1 cm above the horizontal ramus of the mandible.
Vial 3- - 1 cm laterally from the oral commissure
Recommendation: Spread (fanning technique) the product according to your patient´s needs in order to achieve a tailored made result and the best outcome.
VOLUME PER SIDE
2,5 - 75mg PLLA Lasynpro
TREATMENT INTERVAL
3 sessions were performed.
Each treatment/vial 4 weeks apart.
If previous material( calcium hydroxyapatite, polycaprolactone etc) my personal professional experience it is to at least wait 6 months after the last injection of those material was performed, in case any delayed complications from that previous material could appear.
LONG TERM PLAN
For this patient, currently, 1-2 vial of Julaine per year was recommended.
PATIENT AGE
54
PREVIOUS TREATMENT
None
INJECTION TECHNIQUE
Fanning on both sides of the face.
CANNULA
25 G cannula was used, subdermal.
3
PATIENT
ENTRY POINT
Vial 1 -At the intersection of a parallel line located 1 cm in front of the vertical ramus of the mandible with the parallel line 1 cm above the horizontal ramus of the mandible.
Vial 2 -
- 1 cm laterally from the oral commissure
-At the intersection of a parallel line located 1 cm in front of the vertical ramus of the mandible with the parallel line 1 cm above the horizontal ramus of the mandible.
Vial 3- - 1 cm laterally from the oral commissure
Recommendation: Spread (fanning technique) the product according to your patient´s needs in order to achieve a tailored made result and the best outcome.
VOLUME PER SIDE
2,5 - 75mg PLLA Lasynpro
TREATMENT INTERVAL
6 sessions were performed.
Each treatment/vial 4 weeks apart.
If previous material( calcium hydroxyapatite, polycaprolactone etc) my personal professional experience it is to at least wait 6 months after the last injection of those material was performed, in case any delayed complications from that previous material could appear.
LONG TERM PLAN
For this patient, currently, 1-2 vial of Julaine per year was recommended.
PATIENT AGE
43
PREVIOUS TREATMENT
None
INJECTION TECHNIQUE
Fanning on both sides of the face.
CANNULA
25 G cannula was used, subdermal.
